175 related articles for article (PubMed ID: 29728539)
1. Immunohistochemical Detection of Proliferative Marker Ki-67 in Benign and Malignant Salivary Gland Tumors.
Bussari S; Ganvir SM; Sarode M; Jeergal PA; Deshmukh A; Srivastava H
J Contemp Dent Pract; 2018 Apr; 19(4):375-383. PubMed ID: 29728539
[No Abstract] [Full Text] [Related]
2. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
[TBL] [Abstract][Full Text] [Related]
3. MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors.
Ashkavandi ZJ; Najvani AD; Tadbir AA; Pardis S; Ranjbar MA; Ashraf MJ
Asian Pac J Cancer Prev; 2013; 14(6):3479-82. PubMed ID: 23886132
[TBL] [Abstract][Full Text] [Related]
4. Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors.
Tadbir AA; Pardis S; Ashkavandi ZJ; Najvani AD; Ashraf MJ; Taheri A; Zadeh MA; Sardari Y
Asian Pac J Cancer Prev; 2012; 13(10):5155-9. PubMed ID: 23244127
[TBL] [Abstract][Full Text] [Related]
5. The potential of somatostatin receptor 2 as a novel therapeutic target in salivary gland malignant tumors.
Meirovitz A; Shouchane-Blum K; Maly A; Bersudski E; Hirshoren N; Abrams R; Popovtzer A; Orevi M; Weinberger J
J Cancer Res Clin Oncol; 2021 May; 147(5):1335-1340. PubMed ID: 33598797
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 and p53 immunostaining assessment of proliferative activity in salivary tumors.
Faur AC; Sas I; Motoc AG; Cornianu M; Zamfir CL; Lazăr DC; Folescu R
Rom J Morphol Embryol; 2015; 56(4):1429-39. PubMed ID: 26743291
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Expression of Fatty Acid Synthase (FASN) is Correlated to Tumor Aggressiveness and Cellular Differentiation in Salivary Gland Carcinomas.
de Angelis CM; de Lima-Souza RA; Scarini JF; Egal ESA; do Amaral-Silva GK; de Oliveira Gondak R; de Almeida OP; Chone CT; Kowalski LP; Altemani A; Mariano FV
Head Neck Pathol; 2021 Dec; 15(4):1119-1126. PubMed ID: 33843033
[TBL] [Abstract][Full Text] [Related]
8. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of hoxb7 and hoxb9 in salivary gland tumours.
Fonseca FP; Bingle L; Santos-Silva AR; Lopes MA; Coletta RD; de Andrade BA; Mariano FV; Kowalski LP; Rangel AL; Martins MD; Meurer L; Hunter KD; Speight PM; Vargas PA
J Oral Pathol Med; 2016 Oct; 45(9):672-681. PubMed ID: 26991799
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of the expression of fatty acid synthase and Ki-67 in salivary gland tumors.
do Prado RF; da Silva Machado AL; Colombo CE; Carvalho YR
J Oral Pathol Med; 2011 Jul; 40(6):467-75. PubMed ID: 21385214
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in oral and maxillofacial tumors.
Liao J; Mitsuyasu T; Yamane K; Ohishi M
Oral Oncol; 2000 Jul; 36(4):347-52. PubMed ID: 10899673
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Proliferative Marker Ki-67 in Adenoid Cystic Carcinoma: A Retrospective Study.
Bussari S; Jeergal PA; Sarode M; Namazi NA; Kulkarni PG; Deshmukh A; Kulkarni D
J Contemp Dent Pract; 2019 Feb; 20(2):211-215. PubMed ID: 31058637
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Ki-67 in salivary gland carcinomas.
Larsen SR; Bjørndal K; Godballe C; Krogdahl A
J Oral Pathol Med; 2012 Sep; 41(8):598-602. PubMed ID: 22530699
[TBL] [Abstract][Full Text] [Related]
14. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of epithelial cell adhesion molecule (EpCAM) in mucoepidermoid carcinoma compared to normal salivary gland tissues.
Kamal NM; Salem HM; Dahmoush HM
Arch Oral Biol; 2017 Jul; 79():87-94. PubMed ID: 28347886
[TBL] [Abstract][Full Text] [Related]
16. MCM3 proliferative index is worthier over Ki-67 in the characterization of salivary gland tumors.
Raja R; Shetty DC; Chandrakanta ; Juneja S; Tandon A; Gulati N
Indian J Pathol Microbiol; 2021; 64(1):22-27. PubMed ID: 33433405
[TBL] [Abstract][Full Text] [Related]
17. Correlation of intratumoral lymphatic microvessel density, vascular endothelial growth factor C and cell proliferation in salivary gland tumors.
Americo MG; Marques YM; El Abras Ankha MD; do Prado RF; Carvalho YR
Med Mol Morphol; 2017 Mar; 50(1):17-24. PubMed ID: 27229879
[TBL] [Abstract][Full Text] [Related]
18. Management of adenoid cystic carcinoma of minor salivary glands.
Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D
J Oral Maxillofac Surg; 2006 Jul; 64(7):1114-20. PubMed ID: 16781345
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
Matsubayashi S; Yoshihara T
Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
[TBL] [Abstract][Full Text] [Related]
20. High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas.
Yamazaki M; Fujii S; Murata Y; Hayashi R; Ochiai A
Histopathology; 2010 Jun; 56(7):883-92. PubMed ID: 20497246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
